Nurami Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 14

Nurami General Information

Description

Developer of biomaterials and nanofiber-based matrix designed to improve patient outcomes in various surgical procedures. The company's matrices combine porous scaffold for tissue regeneration enhancement with a novel temperature-sensitive sealant to prevent the entry of pathogens and CSF leaks, enabling surgeons to answer the unmet needs of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972 000-000-0000

Nurami Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 03-Jun-2024 00.00 Completed Generating Revenue
9. Later Stage VC 25-Jan-2024 00.00 Completed Generating Revenue
8. Accelerator/Incubator 00.00 Completed Generating Revenue
7. Accelerator/Incubator 00.00 Completed Generating Revenue
6. Later Stage VC (Series B) 02-Nov-2020 000 00.00 000.00 Completed Generating Revenue
5. Grant 01-Dec-2019 00000 00.000 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jul-2018 000 00.000 Completed Generating Revenue
3. Grant 01-Dec-2017 00000 00.000 Completed Generating Revenue
2. Seed Round 20-Dec-2016 $1.74M $1.74M 00.000 Completed Generating Revenue
1. Grant 01-Apr-2014 $861K Completed Startup
To view Nurami’s complete valuation and funding history, request access »

Nurami Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A 000,000 0000.00 0000.00 00 0000.00 00.000
Ordinary A 0,000,000 000.00 000.00 00 000.00 00.000
To view Nurami’s complete cap table history, request access »

Nurami Patents

Nurami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3144451-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 0000000000
AU-2020316756-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 0000000000
US-20220273842-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 0000000000
EP-4003437-A1 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 0000000000
EP-4003437-A4 A tissue-adhesive matrix and uses thereof Pending 22-Jul-2019 A61L24/0015 0
To view Nurami’s complete patent history, request access »

Nurami Executive Team (5)

Name Title Board Seat Contact Info
Nora Nseir Co-Founder, Co-Chief Executive Officer, Chief Technology Officer & Board Member
Hannoch Marksheid Ph.D Co-Chief Executive Officer & Business Development Manager
Amir Bahar Ph.D Co-Founder, Chief Operating Officer, Clinical Director, Manager of Clinical Lectures & Board Member
Peter Stebbins Executive Chairperson
Nizar Mishael Chief Financial Officer
To view Nurami’s complete executive team members history, request access »

Nurami Board Members (4)

Name Representing Role Since
Amir Bahar Ph.D Nurami Co-Founder, Chief Operating Officer, Clinical Director, Manager of Clinical Lectures & Board Member 000 0000
Doron Birger Self Chairman 000 0000
Peter Stebbins Nurami Executive Chairperson 000 0000
Zohar Gendler Next Generation Technology Board Member 000 0000
To view Nurami’s complete board members history, request access »

Nurami Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
Iron Nation Not-For-Profit Venture Capital 000 0000 000000 0
Almeda Ventures Venture Capital Minority 000 0000 000000 0
GlenRock Israel Growth/Expansion Minority 000 0000 000000 0
Jacobs Investments Family Office Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Nurami FAQs

  • When was Nurami founded?

    Nurami was founded in 2014.

  • Who is the founder of Nurami?

    Nora Nseir and Amir Bahar Ph.D are the founders of Nurami.

  • Who is the CEO of Nurami?

    Nora Nseir and Hannoch Marksheid Ph.D are the CEOs of Nurami.

  • Where is Nurami headquartered?

    Nurami is headquartered in Haifa, Israel.

  • What is the size of Nurami?

    Nurami has 19 total employees.

  • What industry is Nurami in?

    Nurami’s primary industry is Surgical Devices.

  • Is Nurami a private or public company?

    Nurami is a Private company.

  • What is Nurami’s current revenue?

    The current revenue for Nurami is 00000.

  • How much funding has Nurami raised over time?

    Nurami has raised $9.7M.

  • Who are Nurami’s investors?

    MedTech Innovator, Iron Nation, Almeda Ventures, GlenRock Israel, and Jacobs Investments are 5 of 14 investors who have invested in Nurami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »